Health care Field Enforcement Activity January April 2022
PHARMA Manufacturer AGREES TO Spend $260M TO SETTLE LAWSUITS ALLEGING MEDICAID DRUG REBATE UNDERPAYMENTS, Unlawful KICKBACKS On March 9, 2022,...
PHARMA Manufacturer AGREES TO Spend $260M TO SETTLE LAWSUITS ALLEGING MEDICAID DRUG REBATE UNDERPAYMENTS, Unlawful KICKBACKS On March 9, 2022,...